GE HealthCare Faces Securities Fraud Probe After Q1 Profit Cut, 13% Stock Drop
GEHC is trading near its 52-week low of $58.75 (11% above the low).
Summary
Law Offices of Howard G. Smith has launched a securities fraud investigation into GE HealthCare. This follows the company's Q1 2026 earnings report on April 29, 2026, where GE HealthCare significantly cut its full-year adjusted EPS guidance and cited a PDx supplier recall impacting profit. The news led to a 13.2% decline in GEHC shares on that day. A formal investigation could result in substantial legal costs, potential liabilities, and damage to the company's reputation.
At the time of this announcement, GEHC was trading at $65.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.5B. The 52-week trading range was $58.75 to $89.77. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.